Polar Asset Management Partners’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Polar Asset Management Partners’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9K	Hold	743,475	–	–	﹤0.01%	642
2025 Q4	$19.3K	Hold	743,475	–	–	﹤0.01%	628
2025 Q3	$26.2K	Hold	743,475	–	–	﹤0.01%	604
2025 Q2	$30.4K	Hold	743,475	–	–	﹤0.01%	530
2025 Q1	$56.9K	Hold	743,475	–	–	﹤0.01%	421
2024 Q4	$25.5K	Hold	743,475	–	–	﹤0.01%	583
2024 Q3	$23.6K	Buy	+743,475	New	+$43K	﹤0.01%	596

Other funds holding SLXNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Polar Asset Management Partners's SLXNW Position: Q1 2026 in Review

Polar Asset Management Partners held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 743,475 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Polar Asset Management Partners first reported a position in SLXNW in Q3 2024 and has held it in 7 quarters since. The position peaked at $56.9K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

Polar Asset Management Partners held 743,475 shares of Silexion Therapeutics Warrant worth $15.9K as of Q1 2026.
Polar Asset Management Partners left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Polar Asset Management Partners's portfolio in Q1 2026, its #642 holding.
Polar Asset Management Partners first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 7 quarters since.
Polar Asset Management Partners's Silexion Therapeutics Warrant position peaked at $56.9K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Polar Asset Management Partners's 13F filing for Q1 2026, filed 15 May 2026.